INTRODUCTION {#SEC1}
============

Posttranscriptional modification of tRNA is part of the tRNA maturation process during which nascent tRNAs are converted into functional, mature tRNA molecules. To date, \>100 species-specific base modifications have been identified in mature tRNAs, which play a large variety of functions in different biological processes and cellular stress responses. Modifications in the anticodon region, especially at the wobble position (position 34) and position 37, commonly play a major role in ensuring efficient and accurate translation, whereas other modifications found along the tRNA body largely contribute to tRNA structure and stability ([@B1]).

7-Methylguanosine (m^7^G) tRNA modification is widely found in all three domains of life, and it occurs at position 46 in the tRNA variable loop, except in three rare cases: in the mitochondrial tRNA of squid ([@B9]) and starfish ([@B10]) and in chloroplast tRNA ([@B11]), wherein m^7^G modification takes place at the guanosine positions 34 and 36 in the anticodon loop. m^7^G modification is catalyzed by the tRNA guanine N7-methyltransferase, a member of the S-adenosyl methionine (SAM)-dependent RNA methyltransferase enzyme family ([@B12]). This modification is not essential for viability ([@B12],[@B16]). However, it plays an important role in tRNA tertiary structure maintenance, tRNA thermal stability, and cell survival at high temperatures ([@B15],[@B17]).

m^7^G tRNA modification is reported to strengthen tertiary interactions among the base triplet C13-G22-m^7^G46 in the elbow region of tRNA^Phe^, thereby maintaining the L-shaped structure of tRNA ([@B17]). In yeast, loss of m^7^G46 and 5-methylcytidine (m^5^C) modifications causes tRNA^Val/AAC^ degradation via the rapid tRNA degradation (RTD) pathway, resulting in a temperature-sensitive phenotype ([@B18],[@B19]). Furthermore, degradation of specific tRNAs as well as severe growth defects have been observed at high temperatures in an m^7^G-deficient *Thermus thermophilus* strain ([@B15]). At elevated temperatures, hypo-m^7^G46 modification in *T. thermophilus* additionally leads to depleted levels of 2′-*O*-methylguanosine (Gm18) and 1-methylguanosine (m^1^G37) modifications, resulting in specific degradation of tRNA^Phe/GAA^ and tRNA^Ile/GAT^ ([@B15]). Thus, in combination with other modifications, m^7^G46 contributes to tRNA thermal stability and cellular survival at high temperatures.

In humans, m^7^G46 is involved in the pathogenicity of primordial dwarfism (PD). Significant reductions in m^7^G levels in tRNA^Phe/GAA^ and tRNA^Val/AAC^ are observed in PD patients carrying a missense mutation in the gene encoding Wdr4, a component of the human tRNA guanine N7-methyltransferase Wdr4/Mettl1 complex ([@B20]). It has recently been found that Wdr4/Mettl1-mediated m^7^G modification plays an essential role in self-renewal and differentiation of embryonic stem cells (ESCs) in mice ([@B21]). Mettl1 deficiency causes inefficient translation of the codons decoded by m^7^G-modified tRNAs, decreased mRNA levels of genes associated with cell differentiation and brain development, and impaired ESC colony formation ([@B21]).

To date, growing evidence demonstrates the functions of tRNA modifications in response to stresses, especially the modifications in the wobble positions ([@B5],[@B22],[@B23]). In our preliminary screening, we found a possible link between tRNA-modifying enzymes targeting non-wobble position and H~2~O~2~ resistance in *Pseudomonas aeruginosa*, a human pathogenic bacterium. To investigate the role of non-wobble tRNA modification in oxidative stress response, we characterize a *P. aeruginosa* tRNA-modifying enzyme, PaTrmB, which transfers methyl group to the guanosine residue, forming m^7^G at position 46 in the variable loop of tRNA. Moreover, we describe its novel role in the translational control of critical stress response proteins required for the H~2~O~2~ resistance of *P. aeruginosa*. Our data demonstrate the impact of m^7^G46 modification on the efficient translation of Phe- and Asp-enriched mRNAs. Translation of Phe- and Asp-enriched catalase genes, such as *katA* and *katB*, is positively controlled by TrmB in response to H~2~O~2~. Inactivation of *trmB* results in depleted catalase levels and in strong H~2~O~2~-sensitive phenotype, demonstrating the essential role of tRNA m^7^G modification in oxidative stress response.

MATERIALS AND METHODS {#SEC2}
=====================

Bacterial strains, growth conditions, and plasmids {#SEC2-1}
--------------------------------------------------

The strains and plasmids used in this study are listed in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}. *P. aeruginosa* strain UCBPP-PA14 (PA14) and *Escherichia coli* strains BW20767, DH5α and DE3 (BL21) were grown on lysogeny broth (LB) agar plate at 37°C and in LB medium at 37°C with shaking. When needed, antibiotics were added as appropriate at the following concentrations: for *P. aeruginosa*, carbenicillin (Cb) at 200 μg/ml and gentamicin (Gm) at 75 μg/ml; for *E. coli*, gentamicin (Gm) at 15 μg/ml, ampicillin (Ap) at 100 μg/ml, and chloramphenicol (Cm) at 15 μg/ml. All primers and synthesized oligonucleotides used in cloning are listed in [Supplementary Table S2](#sup1){ref-type="supplementary-material"}.

Construction of *trmB* mutant strain {#SEC2-2}
------------------------------------

PA14 *trmB* or *PA14_05000* was disrupted through the insertional knockout technique by using the suicide plasmid pKNOCK-Gm ([@B24]). A 215 bp fragment located within *trmB* was amplified by PCR using *Taq* DNA polymerase and the primer pair BT4381/BT4382. The amplified fragment was cloned into pKNOCK-Gm plasmid digested with *Sma*I according to a standard restriction enzyme digestion and ligation protocol. A recombinant plasmid, pKN-*trmB*, was transferred into the recipient *P. aeruginosa* PA14 through biparental mating, with *E. coli* BW20767 as the donor strain. At the end of the experiment, the *trmB* mutant was verified by colony PCR and Southern blot analysis.

Construction of *trmB* complemented strain {#SEC2-3}
------------------------------------------

The full length sequence of *trmB* was amplified with the primers BT4767, BT4768 and *Pfu* polymerase by PCR followed by cloning into the *Sma*I site of the broad-host-range vector pBBR1MCS-4 ([@B25]), producing a pBB-*trmB*-FL plasmid. A verified pBB-*trmB*-FL plasmid was electroporated into the *trmB* mutant strain, producing *trmB* complemented strain, which was selected by plating on LB agar plate that contains 200 μg/ml Cb and 75 μg/ml Gm.

Expression and purification of PaTrmB recombinant protein {#SEC2-4}
---------------------------------------------------------

The full length of PA14 *trmB* was PCR-amplified with *Pfu* DNA polymerase, with forward primer BT5330 containing *Nco*I site, and with reverse primer BT5331 containing *Xho*I site. A *Nco*I-*Xho*I fragment containing full-length *trmB* was subsequently cloned into the expression vector pETBLUE-2 (Novagen) at the *Nco*I--*Xho*I site. For protein production, the expression host *E. coli* DE3 (BL21) harboring a verified pET-*trmB*-FL plasmid was grown to the exponential phase and induced with 200 μM isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside at 37°C for 2--4 h. 6XHis-tagged proteins were eluted with a gradient of 200--500 mM imidazole and analyzed by SDS-PAGE. The final yield of recombinant PaTrmB protein was measured by Bradford assay ([@B26]). The purity of the PaTrmB was estimated to be \>99% on a Coomassie blue stained SDS-polyacrylamide gel ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). Aliquots of the purified recombinant PaTrmB protein were stored at −20°C before use.

Extraction and purification of *in vivo* total tRNA {#SEC2-5}
---------------------------------------------------

Cells were harvested and extracted using TRIzol^®^ Reagent (Thermo Fisher Scientific). Large RNA species were precipitated in a cold solution of 35% absolute ethanol. Pellets of these large RNA species were separated from small RNA species by centrifugation at 12 000 × *g* for 5 min at 4°C. The aqueous phase containing the small RNA species was subsequently transferred into a new tube, precipitated using 2 volumes of absolute ethanol at −70°C for 2 h, and resuspended in 50 μl of RNase-free water. The total tRNA was isolated by HPLC as previously described ([@B27]).

*In vitro* preparation of tRNA {#SEC2-6}
------------------------------

Thirty-eight tRNA types were synthesized *in vitro* using a MEGAshortscript^TM^ Kit (Ambion). Double-stranded DNA templates for the MEGAshortscript^TM^ Kit were prepared from synthesized fragments containing the T7 promoter located upstream of the candidate target tRNA ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}). Each synthesized fragment was amplified by PCR using *Phusion* DNA polymerase, T7 forward primer, and a specific reverse primer listed in [Supplementary Table S2](#sup1){ref-type="supplementary-material"}. The reactions were assembled and incubated at 37°C for 4 h. The tRNA transcripts were purified from the reactions by HPLC ([@B27]).

Analysis of the modified ribonucleosides by LC-QQQ {#SEC2-7}
--------------------------------------------------

Five micrograms of total tRNA was treated with Benzonase nuclease (Sigma), bacterial alkaline phosphatase (Invitrogen), and phosphodiesterase in the presence of deaminase inhibitors (0.5 μg/ml coformycin and 5 μg/ml tetrahydrouridine) and antioxidants (50 μM desferrioxamine and 50 μM butylatedhydroxytoluene) at 37°C overnight to generate ribonucleoside products. Proteins were removed from the digested product by filtration with 10K MWCO columns (Ambion). The ribonucleosides were fractionated by using a reversed-phase column (Thermo Hypersil Gold aQ column) with a gradient made of solvent A (0.1% formic acid in water) and solvent B (0.1% formic acid in acetonitrile) prior to introduction into an electrospray ionization triple quadrupole mass spectrometer (Agilent 6470), which was operated in the positive ion mode as described previously ([@B27],[@B28]). The modified ribonucleosides were identified by their HPLC retention times, CID fragmentation patterns, fragmentor voltages, and collision energies in comparison with available chemical synthetic standards. The level of each modified ribonucleoside was quantified from the MRM signal intensity and normalized by dividing by the summed signals of adenosine, guanosine, cytidine and uridine from the sample.

tRNA methyltransferase assays {#SEC2-8}
-----------------------------

*In vitro* methyltransferase assays (MTase assay) were performed using the MTase-Glo™ Bioluminescent Assay Kit (Promega) to assess methyltransferase activity and to identify the tRNA substrates of PaTrmB. The 20 μl MTase reaction mixtures consisting of 3 μg tRNA, 5 μM recombinant PaTrmB protein, 50 mM Tris--HCl (pH 8.0), 5 mM MgCl~2~, 50 mM KCl, 50 μM SAM and 1x MTase-Glo™ reagent. For detection, 1 volume of MTase-Glo™ detection solution was added. The light signal corresponding to the amount of S-adenosyl homocysteine (SAH) produced by the PaTrmB methyltransferase activity was subsequently measured using a microplate luminometer (Thermo Fisher Scientific). The reactions without PaTrmB were used as negative control.

Localization of the modified ribonucleosides by LC-QTOF {#SEC2-9}
-------------------------------------------------------

The 80 μl MTase reaction mixtures consisting of 10 μg T7 *in vitro* tRNA transcript, 5 μM recombinant PaTrmB protein, 50 mM Tris--HCl (pH 8.0), 5 mM MgCl~2~, 50 mM KCl and 50 μM SAM (Sigma) were assembled and incubated at 37°C for 1 h. The m^7^G-modified tRNA was subsequently purified from the MTase reaction mixtures by filtration using 10K MWCO columns (Ambion). Five micrograms of methylated tRNA was digested into fragments with RNase T1 or RNase U (Invitrogen) and then dephosphorylated with bacterial alkaline phosphatase (Invitrogen) at 37°C for 4 h in the presence of deaminase inhibitors and antioxidants. To purify the digested fragments from the solution, 100 μl of the digestion reaction was applied to Strata™ solid-phase extraction columns (Phenomenex). The purified fragments were then fractionated on TSK-gel Amide-80 column (2.0 mm ID × 150 mm, 3 μm particle size) with a gradient made of solvent A (8 mM ammonium acetate) and solvent B (100% acetonitrile) before sequencing using a quadrupole time-of-flight mass spectrometer (Agilent 6520) operated in negative ion mode as previously described ([@B27]).

Viability analysis to assess H~2~O~2~ sensitivity {#SEC2-10}
-------------------------------------------------

Exponential-phase cultures were diluted in LB medium to a final OD~600~ of 0.1. H~2~O~2~ was added to the treated cultures, and cultures without H~2~O~2~ exposure served as the untreated control. After H~2~O~2~ addition, the cultures were incubated at room temperature without shaking for 25 min. Serial dilutions of the treated and untreated cultures were prepared, and 10 μl aliquots were dropped onto LB agar plates without antibiotic. The cells were grown on the plates at 37°C, and the sensitivity of the treated cultures to H~2~O~2~ was observed within 24 h.

Codon reporter assay {#SEC2-11}
--------------------

The effects of m^7^G46 modification on the translation of transcripts enriched with codons decoded by the tRNA substrates of PaTrmB were assayed *in vivo* using β-galactosidase reporter plasmids ([@B29],[@B30]). The experimental reporters containing codon bias fragment were used to examine the translation of the codons of interest, whereas the control reporter without codon bias was used to examine the general translation and to normalize the translation background. In constructing the experimental and control reporters, DNA fragments with codon bias or a control fragment without codon bias ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}) was cloned in-frame with the *lacZ* gene in the pPR9TT translational fusion plasmid ([@B31]) under the control of ampicillin resistance promoter (P~ApR~). Recombinant plasmids ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}) were introduced into the wild type and *trmB* mutant cells. The exponential-phase cultures of the transformants were treated with 10 mM H~2~O~2~ for 25 min. β-Galactosidase activity was measured using the Miller\'s method ([@B32]), and the activity of empty pPR9TT plasmid was subtracted from the β-galactosidase activity of the experimental and control reporters before calculating the translation efficiency. Translational efficiency was calculated as the ratio of the β-galactosidase activities (Miller unit) of the experimental reporters to the activity of control reporter without codon bias.

Total catalase activity assay {#SEC2-12}
-----------------------------

Cell pellets were harvested by centrifugation at 3400 × *g* for 10 min at 4°C and were washed three times with cold 50 mM phosphate buffer. Crude protein was extracted by sonication. Protein concentration was measured by Bradford assay. Specific catalase activity (U/mg protein) was measured by a spectrophotometric method (*A*~420~, light path = 1 cm) using 10 mM H~2~O~2~ in 50 mM phosphate buffer (pH 7.0) as substrate. U was defined as one unit of catalase decomposing 1.0 μmol of H~2~O~2~ per minute at pH 7.0 at 25°C.

Catalase gel activity assay {#SEC2-13}
---------------------------

Thirty micrograms of total protein was separated on an 8% native polyacrylamide gel. Gel staining for catalase activity was performed using the di-amino benzidine (DAB) staining method ([@B33]). The gel was soaked in renaturation buffer \[40 mM Tris--HCl (pH 8.0), 2 mM MgCl~2~ and 0.1% v/v Triton-X 100\] at 4°C overnight and then washed twice with 50 mM phosphate buffer (pH 6.0) before soaking in 50 mM phosphate buffer (pH 6.0) containing 50 μg/μl horseradish peroxidase (Sigma, USA) for 45 min at room temperature. The gel was subsequently incubated in 50 mM phosphate buffer (pH 6.0) containing 10 mM H~2~O~2~ for 10 min, washed with distilled water, and then soaked in 50 mM potassium phosphate buffer (pH 6.0) containing 500 μg/μl DAB to develop a brown background. Colorless bands indicate the area where H~2~O~2~ is decomposed by catalase.

Western blot analysis {#SEC2-14}
---------------------

Total protein was extracted from cells by sonication. Fifty micrograms of total protein was separated using 12.5% SDS-PAGE electrophoresis and then transferred onto polyvinylidene difluoride (PVDF) membranes (GE Healthcare). The membranes were blocked in TBST buffer \[20 mM Tris--HCl (pH 7.5), 150 mM NaCl and 0.05% Tween 20\] containing 5% skim milk on an orbital shaker for 1 h at room temperature followed by incubation in an antibody solution (HRP-conjugated antibody diluted in 3% skim milk and 1% BSA in TBST) for 1 h. The membranes were washed three times for 30 min with TBST buffer. The target protein was detected using a chemiluminescent (ECL) detection reagent kit (GE Healthcare) according to the manufacturer\'s instructions.

For western blot analysis of KatB, a his-tag approach was used given that anti-KatB antibody was unavailable in our laboratory. The full length *katB* gene was amplified with the BT5515/BT5755 primer pair by PCR and cloned in-frame with the C-terminus hexahistidine tag in the *Sma*I--*Xho*I site of the pETBlue-2 plasmid (Novagen), producing the recombinant plasmid pET-*katB*-6XHis. The *katB*-6XHis fragment was further amplified from the pET-*katB*-6XHis plasmid using the pETUP/pETDOWN primer pair and subcloned into the *Eco*RV site of the pBBR1MCS-4 vector for gene expression in PA14. The resulting plasmid, pBB-*katB*-6XHis, was verified by sequencing before introduction into the wild type and *trmB* mutant strains for Western blot analysis.

Semiquantitative real-time PCR {#SEC2-15}
------------------------------

Total RNA was extracted according to a hot acid phenol extraction protocol ([@B34]). The residual DNA in the sample was eliminated by DNase treatment (Thermo Fisher Scientific). For cDNA synthesis, a reverse transcription reaction was performed using random hexa-primers and a RevertAid^TM^ M-MuLV Reverse Transcriptase Kit (Thermo Fisher Scientific). Semiquantitative real-time PCR was performed using KAPA SYBR FAST reagent (KAPA Biosystems) and a StepOnePlus^TM^ real-time PCR system (Thermo Fisher Scientific) according to the manufacturers' instructions. The specific primers for *trmB, oxyR, katA, katB, katE, ahpB, ahpC, ankB* and *recG* are listed in [Supplementary Table S2](#sup1){ref-type="supplementary-material"}. 16S ribosomal RNA gene was used as internal control to normalize the gene expression.

Statistical analysis {#SEC2-16}
--------------------

Statistical analysis was performed using Graphpad Prism (Graphpad Software). *t*-test was used to determine the statistical significance. The levels of statistical significance were indicated in each experiment.

RESULTS {#SEC3}
=======

*P. aeruginosa trmB* gene encodes a tRNA guanine-N7-methyltransferase that catalyzes m^7^G formation in tRNA {#SEC3-1}
------------------------------------------------------------------------------------------------------------

PaTrmB (PA14_05000) displays high identity (60%) and similarity (73%) scores with the experimentally identified *E. coli* TrmB, which is a tRNA guanine-N7-methyltransferase ([@B12]). Analysis of the PaTrmB sequence revealed the presence of GXGXG, a SAM-binding site ([@B35]) at residue 71--75; GXGXG belongs to the Rossmann-fold SAM-dependent methyltransferase superfamily (Figure [1](#F1){ref-type="fig"}). To test whether PaTrmB functions as a tRNA guanine N7-methyltransferase, PaTrmB was purified for *in vitro* assays.

![PaTrmB shows high identity and similarity scores with *Escherichia coli* TrmB. A sequence alignment of PaTrmB and *E. coli* K12 TrmB was performed using ENDscript 2.0 (ENDscript 2.0; <http://endscript.ibcp.fr/ESPript/ENDscript/>). PaTrmB shows identity and similarity scores of 60% (126/209) and 73% (154/209), respectively, with the *E. coli* TrmB. Black box, identity; white box, similarity in a group.](gkz702fig1){#F1}

The methyltransferase activity of *trmB* was assessed *in vitro* using an MTase-Glo^TM^ Methyltransferase Assay Kit (Promega). Recombinant PaTrmB protein was incubated with the *in vivo* tRNA extracted from the wild type, *trmB* mutant, or complemented strains in the presence of SAM as methyl donor. As shown in Figure [2A](#F2){ref-type="fig"}, the amount of the reaction product S-adenosyl homocysteine (SAH) represents the degree of methyltransferase activity. We found that the recombinant PaTrmB protein effectively functioned *in vitro* in the presence of the hypo-methylated tRNA substrate and of the methyl donor SAM. After 1 h of incubation at 37°C, the total tRNA extracted from the *trmB* mutant strain produced the highest amount of SAH (3785±474 nM), which is significantly higher (*P* ≤ 0.001) than that obtained when the tRNA from the wild type or complemented strains was used as substrate (219±6 and 2441±82 nM, respectively). Although we expected that the reaction containing the tRNA from the wild type and complemented strains would share similar SAH levels, the amount of SAH produced in the reaction containing the tRNA from the complemented strain was higher, indicating partial methylation when *trmB* is expressed from a multiple-copy plasmid (pBB-*trmB*-FL) after reintroduction into the *trmB* mutant strain.

![PaTrmB functions as tRNA methyltransferase *in vitro* and is responsible for m^7^G tRNA formation *in vivo*. (**A**) The recombinant PaTrmB protein effectively methylates the tRNA isolated from the *trmB* mutant strain. The amount of SAH produced by the PaTrmB methyltransferase activity was measured using an MTase-Glo™ Methyltransferase Assay Kit (Promega). The reactions without PaTrmB served as negative control. (**B**) Inactivation of *trmB* leads to specific m^7^G hypo-modification. The relative levels of m^7^G modification (as compared with that in the wild type strain) in the total tRNA extracted from the wild type, *trmB* mutant, or *trmB* complemented strains were assessed using LC-QQQ and were calculated based on the normalized signal intensity of its own sample. Data represent the mean ± SD for three biological replicates. Asterisks denote a significant difference by *t*-test (\*\**P* ≤ 0.01, \*\*\**P* ≤ 0.001, \*\*\*\**P* ≤ 0.0001).](gkz702fig2){#F2}

Next, to determine whether *trmB* is responsible for the m^7^G tRNA modification, the individual-modified ribonucleosides from the *in vivo* total tRNA of the wild type, *trmB* mutant, or complemented strains were identified and quantified using an LC-QQQ with 24 modified nucleoside standards; 20 modifications were identified in the *P. aeruginosa* total tRNA. Among the modifications, only the m^7^G modification was significantly reduced (*P* ≤ 0.001) in the total tRNA isolated from the *trmB* mutant strain compared with the modification in the tRNA isolated from the wild type and complemented strains (Figure [2B](#F2){ref-type="fig"} and [Supplementary Table S3](#sup1){ref-type="supplementary-material"}). In good agreement with the partial methylation observed in the *in vitro* MTase assay (Figure [2A](#F2){ref-type="fig"}), the abundance of m^7^G in the tRNA extracted from *trmB* complemented strain was ∼50% lower than the abundance of m^7^G extracted from the wild type strain (Figure [2B](#F2){ref-type="fig"}).

*P. aeruginosa* TrmB catalyzes m^7^G46 formation in the tRNA variable loop {#SEC3-2}
--------------------------------------------------------------------------

To identify the tRNA substrates of PaTrmB, all 38 tRNA species in *P. aeruginosa* (<http://gtrnadb2009.ucsc.edu>) were *in vitro* synthesized using a MEGAshortscript™ Kit (Ambion). The *in vitro* synthetized tRNAs were subsequently *in vitro* methylated by recombinant PaTrmB. In *P. aeruginosa*, 26 tRNAs contain G at position 46 (G46) (Figure [3](#F3){ref-type="fig"}, black bar). We found that 23 of the 26 G46-containing tRNAs gave higher SAH signals compared with the G46-lacking tRNAs (Figure [3](#F3){ref-type="fig"}, white bar), namely, tRNA^Ala/GGC^, tRNA^Ala/UGC^, tRNA^Arg/ACG^, tRNA^Arg/CCG^, tRNA^Arg/CCU^, tRNA^Arg/UCU^, tRNA^Asn/GUU^, tRNA^Asp/GUC^, tRNA^Gly/GCC^, tRNA^His/GUG^, tRNA^Ile/GAU^, tRNA^Lys/UUU^, tRNA^Met/CAU^, tRNA^Phe/GAA^, tRNA^Pro/CGG^, tRNA^Pro/GGG^, tRNA^Pro/UGG^, tRNA^Thr/CGU^, tRNA^Thr/GGU^, tRNA^Thr/UGU^, tRNA^Trp/CCA^, tRNA^Val/GAC^ and tRNA^Val/UAC^. However, there was little, if any, SAH signals when three other G46-containing tRNAs (tRNA^Leu/CAG^, tRNA^Leu/GAG^, and tRNA^Sec(p)/UCA^) were used as substrate, suggesting that these tRNAs might not be substrates of PaTrmB (Figure [3](#F3){ref-type="fig"}). As expected, all tRNAs lacking G46 yielded considerably low amount of SAH (Figure [3](#F3){ref-type="fig"}). Thus, we hypothesized that PaTrmB transfers a methyl group strictly to the G residue at position 46.

![Identification of PaTrmB tRNA substrates. *In vitro* transcribed tRNAs were used as substrates for the purified PaTrmB, with SAM as methyl donor. Methylation reaction was assessed using an MTase-Glo™ Methyltransferase Assay Kit (Promega) according to the manufacturer\'s instructions. The reaction without PaTrmB served as control. The tRNA transcripts containing G46 are shown as black bars, whereas those lacking G46 are shown as white bars. Data represent the mean ± SD for three biological replicates.](gkz702fig3){#F3}

To confirm whether PaTrmB catalyzes m^7^G modification at position 46, LC-QTOF mass spectrometric analysis was performed. Six PaTrmB substrates, the synthetic T7 transcription products of tRNA^Asn/GUU^, tRNA^Asp/GUC^, tRNA^Gly/GCC^, tRNA^Phe/GAA^, tRNA^Thr/GGU^ and tRNA^Val/GAC^, were individually incubated with recombinant PaTrmB, with SAM as methyl donor. Following *in vitro* methylation, each methylated tRNA was digested into fragments with RNase T1 or RNase U, dephosphorylated, and subjected to mass spectrometric analysis. Analysis of the methylated tRNA treated with RNase revealed that the m^7^G-modified base was located at position 46 in the tRNA variable loop (Figure [4](#F4){ref-type="fig"}). After RNase T1 digestion, the sequence of the tRNA fragment containing G46 is GUCG, covering the base positions 46--49 for tRNA^Asp/GUC^, and UGUCG, covering the base positions 45--49 for tRNA^Phe/GAA^. The extracted ion chromatogram of the RNase T1-digested fragments from tRNA^Asp/GUC^ and tRNA^Phe/GAA^ are shown in Figure [4A](#F4){ref-type="fig"} and [D](#F4){ref-type="fig"}, respectively. Ion chromatograms of m^7^GUCG (*m/z* of 625.6008) from tRNA^Asp/GUC^ and of Um^7^GUCG (*m/z* of 778.6142) from tRNA^Phe/GAA^ were detected at 21.9 and 21.7 min, respectively. Mass spectra indicating a doubly charged negative ion (M -- 2H)^−2^ of the m^7^GUCG and Um^7^GUCG fragments are shown in Figure [4B](#F4){ref-type="fig"} and [E](#F4){ref-type="fig"}, respectively. The w~1~, w~2~, y~1~ and y~3~ ion products of *m/z* 625.6008 and the w~1~, w~3~ and a~2~-B~2~ ion products of *m/z* 778.6142 were consistent with the m^7^GUCG and Um^7^GUCG sequences, respectively, indicating the presence of m^7^G at position 46 (Figure [4C](#F4){ref-type="fig"} and [F](#F4){ref-type="fig"}). Furthermore, m^7^G formation at position 46 by PaTrmB in tRNA^Asn/GUU^, tRNA^Gly/GCC^, tRNA^Thr/GGU^ and tRNA^Val/GAC^ was also confirmed ([Supplementary Figures S2 and S3](#sup1){ref-type="supplementary-material"}).

![PaTrmB catalyzes m^7^G formation at position 46 in the variable loops of tRNA^Asp/GUC^ and tRNA^Phe/GAA^*in vitro*. (**A**) Extracted ion chromatogram of the m^7^GUCG fragment with an *m/z* of 625.6008; this fragment is an RNase T1-digestion product of tRNA^Asp/GUC^. (**B**) The mass spectrum of the m^7^GUCG fragment shows a doubly charged negative ion with an *m/z* of 625.6008. (**C**) CID spectrum and CID fragmentation pattern of *m/z* 625.6008 with w~1~, w~2~, y~1~ and y~3~ ion products. (**D**) Extracted ion chromatogram of the Um^7^GUCG fragment with an *m/z* of 778.6142; this fragment is an RNase T1-digestion product of tRNA^Phe/GAA^. (**E**) The mass spectrum of the Um^7^GUCG fragment shows a doubly charged negative ion with an *m/z* of 778.6142. (**F**) CID spectrum and CID fragmentation pattern of *m/z* 778.6142 with w~1~, w~3~ and a~2~-B~2~ ion products.](gkz702fig4){#F4}

Taken together, these results clearly demonstrated that *P. aeruginosa trmB* encodes a tRNA guanine (46)-N7-methyltransferase that catalyzes the transfer reaction of a methyl group from SAM to the N7 atom of guanine at position 46 in the tRNA variable loop.

Lack of m^7^G46 modification leads to decreased translation efficiency of transcripts enriched with codons decoded by tRNA^Phe/GAA^ and tRNA^Asp/GUC^ {#SEC3-3}
-----------------------------------------------------------------------------------------------------------------------------------------------------

To investigate the role of *trmB* in protein synthesis, we examined *in vivo* the impact of m^7^G46 tRNA modification on the translation of transcripts enriched with codons decoded by PaTrmB tRNA substrates, including the Ala-GCC, Arg-CGU, Asn-AAC, Asp-GAC, Asp-GAU, Ile-AUC, Phe-UUC, Phe-UUU and Val-GUC codons, by using a codon reporter assay. We cloned a control fragment without codon bias as well as experimental fragments containing 5X codon runs decoded by PaTrmB tRNA substrates and a negative control fragment carrying a repeat of the Gln-CAA codon into the pPR9TT vector under the control of the ampicillin resistance promoter and in frame with the *lacZ* gene (Figure [5A](#F5){ref-type="fig"}). The abilities of the wild type and *trmB* mutant strains to translate the engineered fragments were expressed as the translation efficiency, which was calculated by taking the ratio of the β-galactosidase activity of the experimental reporter to the activity of the control reporter without codon bias.

![TrmB affects the translation of codons decoded by tRNA^Phe/GAA^ and tRNA^Asp/GUC^. (**A**) Design of the reporter system. Each synthesized fragment was cloned into the pPR9TT-P~ApR~ vector in frame with *lacZ* under the control of the P~ApR~ constitutive promoter. Relative translation efficiencies of (**B**) 5XGln-CAA reporter (negative control), (**C**) 5XPhe-UUC reporter, (**D**) 5XPhe-UUU reporter, (**E**) 5XAsp-GAC reporter and (**F**) 5XAsp-GAU reporter in the wild type and *trmB* mutant strains after H~2~O~2~ exposure. Data represent the mean ± SD for four biological replicates. Asterisks denote a significant difference by *t*-test (\*\**P* ≤ 0.01, \*\*\**P* ≤ 0.001, \*\*\*\**P* ≤ 0.0001). Q, glutamine; F phenylalanine; D, aspartic acid.](gkz702fig5){#F5}

Comparison of translation efficiency between the wild type and *trmB* mutant strains showed that loss of *trmB* specifically affected the translation of Phe and Asp codons decoded by the m^7^G-modified tRNA^Phe/GAA^ and the m^7^G-modified tRNA^Asp/GUC^, respectively, but it exerted no effect on the translation of Gln-CAA (the negative control codon) (Figure [5B](#F5){ref-type="fig"}). Despite the fact that the Ala-GCC, Arg-CGU, Asn-AAC, Asp-GAC, Asp-GAU, Ile-AUC, Phe-UUC, Phe-UUU and Val-GUC codons are all recognized by the PaTrmB tRNA substrates, we did not observe any differences in translation efficiency between the wild type and *trmB* mutant strains for the 5XAla-GCC, 5XArg-CGU, 5XAsn-AAC, 5XIle-AUC and 5XVal-GUC reporters ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}). By contrast, the translation efficiency of the 5XPhe-UUC, 5XPhe-UUU, 5XAsp-GAC and 5XAsp-GAU reporters significantly decreased (*P* ≤ 0.01) in the *trmB* mutant strain under both normal and H~2~O~2~ stress conditions (Figure [5C](#F5){ref-type="fig"}--[F](#F5){ref-type="fig"}). Furthermore, we found that the translation efficiency of these four reporters significantly increased (*P* ≤ 0.01) in the wild type strain after treatment with 10 mM H~2~O~2~ (Figure [5C](#F5){ref-type="fig"}--[F](#F5){ref-type="fig"}), suggesting a relationship between *trmB*-mediated Phe and Asp codon translation and oxidative stress response.

*trmB* plays an important role in the H~2~O~2~ stress response in *P. aeruginosa* {#SEC3-4}
---------------------------------------------------------------------------------

We examined the survival of the wild type, *trmB* mutant, and complemented strains after H~2~O~2~ exposure. Exponential-phase cultures were exposed to 1, 5, 10 or 20 mM H~2~O~2~ for 25 min at 37°C. Untreated cultures were used as control (which showed 100% survival). The *trmB* mutant strain, which lacks tRNA m^7^G46 modification, displayed a hypersensitive phenotype to H~2~O~2~. The survival levels of *trmB* mutant cells exposed to 10 and 20 mM H~2~O~2~ dropped by more than 50% and 90%, respectively, relative to that of the wild type strain. Importantly, the % survival of the *trmB* complemented strain was recovered during H~2~O~2~ stress, indicating that the H~2~O~2~-sensitive phenotype is *trmB*-dependent (Figure [6A](#F6){ref-type="fig"}). To investigate the pattern of m^7^G tRNA modification after H~2~O~2~ exposure in the wild type PA14, the abundance of m^7^G modification was monitored by using LC-MS/MS. We found a slight but significant (*P* ≤ 0.0001) increase in the level of m^7^G tRNA modification in the total tRNA after H~2~O~2~ exposure. m^7^G modification in total tRNA was induced by approximately 12% and 23% after exposure to 1 and 10 mM H~2~O~2~, respectively (Figure [6B](#F6){ref-type="fig"}). We further measured the mRNA level of *trmB* and found a 2.6-fold increase when the wild type cells were exposed to H~2~O~2~ (Figure [6C](#F6){ref-type="fig"}), suggesting that the increased m^7^G level is due to the upregulation of *trmB*. Taken together, these results demonstrated an important role of *trmB* in the H~2~O~2~ stress response in *P. aeruginosa*.

![*trmB* plays an important role in H~2~O~2~ stress response. (**A**) Survival of the wild type, *trmB* mutant, and complemented strains after H~2~O~2~ treatment. Cultures without H~2~O~2~ treatment served as the untreated control (100% survival). (**B**) Induction percentages of m^7^G tRNA modification after exposure to 1 or 10 mM H~2~O~2~ in wild type cells compared with those in untreated cells. (**C**) Relative expression of *trmB* in wild type cells after H~2~O~2~ exposure. Data represent the mean ± SD for three biological replicates for (A) and (C) and the mean ± SD for six biological replicates for (B). Asterisks denote a significant difference by *t*-test (\**P* ≤ 0.05, \*\**P* ≤ 0.01, \*\*\**P* ≤ 0.001, \*\*\*\**P* ≤ 0.0001).](gkz702fig6){#F6}

KatA and KatB protein levels are reduced in the *trmB* mutant strain {#SEC3-5}
--------------------------------------------------------------------

To obtain insight into the mechanism as to how TrmB mediates the H~2~O~2~ stress response and to identify the TrmB-regulated genes, we first assessed the impact of loss of *trmB* on the activity of the catalase enzymes given that catalase is a major H~2~O~2~-detoxifying enzyme ([@B36],[@B37]). The results showed that inactivation of *trmB* led to reduced catalase activity. As shown in Figure [7A](#F7){ref-type="fig"}, the total catalase activity of the *trmB* mutant strain was significantly lower (*P* ≤ 0.01) than that of the wild type and complemented strains. In contrast to that of the wild type strain, whose total catalase activity increased by two-fold in response to H~2~O~2~ treatment, the total catalase activity of the *trmB* mutant strain did not change under any of the conditions regardless of whether H~2~O~2~ was added or not. Complementation of *trmB* mutation fully recovered the ability of the *trmB*-deficient mutant to increase its total catalase activity back to the H~2~O~2~-induced level of the wild type strain; these results demonstrated that the change in the total catalase activity in response to H~2~O~2~ exposure is *trmB-*dependent. In *P. aeruginosa*, three catalases are found, namely, KatA, KatB and KatE; KatA and KatB play important roles during logarithmic growth ([@B37],[@B38]). We further investigated the activity of KatA, the major catalase during the logarithmic growth, using catalase gel staining assay. Consistent with the total catalase activity, KatA activity decreased in the *trmB* mutant strain compared with that in the wild type strain under both normal and H~2~O~2~ treatment conditions (Figure [7B](#F7){ref-type="fig"}). However, the activity of KatB in PA14 was dramatically low and could not be detected in the catalase gel even after H~2~O~2~ treatment or even when the amount of the total protein loaded was increased to 100 μg (data not shown).

![*trmB* exerts effects on catalases. (**A**) Total catalase activities of the wild type, *trmB* mutant, and complemented strains upon exposure to H~2~O~2~. (**B**) Comparison of KatA activities of the wild type and *trmB* mutant strains. KatA activity was examined by a catalase gel activity assay. The colorless band indicates the area where H~2~O~2~ was decomposed; M indicates the protein molecular weight markers. (**C**) Western blot analysis of OxyR, KatA and KatB proteins. OxyR and KatA levels were assessed using anti-OxyR and anti-KatA antibodies, respectively. The amount of KatB protein overexpressed from the pBB-*katB*-6XHis plasmid was assessed using anti-6X-His antibody. The amount of total protein loaded in each gel was shown as loading control. (**D**) Relative expression levels of *katA, katB, katB*-His, and *oxyR* in the wild type and *trmB* mutant strains upon H~2~O~2~ exposure. Data represent the mean ± SD for three biological replicates for (A) and for five biological replicates for (D). Asterisks denote a significant difference by *t*-test (\* *P* ≤ 0.05, \*\* *P* ≤ 0.01).](gkz702fig7){#F7}

To test whether the low catalase activity is due to reduced catalase protein levels, we performed a western blot analysis to detect the protein levels of the catalases. As shown in Figure [7C](#F7){ref-type="fig"}, [a](#F7){ref-type="fig"} clear reduction in KatA (seven-fold decrease at 0 mM H~2~O~2~ and three-fold decrease at 5 mM H~2~O~2~) and KatB (2-fold decrease at 0 mM H~2~O~2~ and 3-fold decrease at 5 mM H~2~O~2~) protein levels was observed in the *trmB* mutant strain compared with that in the wild type strain under both normal and oxidative stress conditions. Semiquantitative real-time PCR analysis revealed that the transcript levels of *katA, katB* and *katB*-His were *trmB*-independent throughout the H~2~O~2~ treatment (Figure [7D](#F7){ref-type="fig"}). These results suggested that *trmB* plays a role in mediating the H~2~O~2~ stress response in *P. aeruginosa* at the translational level by positively controlling the levels of KatA and KatB.

Transcription of *katA* and *katB* is positively regulated by OxyR, an H~2~O~2~-sensing transcriptional regulator ([@B39],[@B40]). To confirm that *trmB* directly regulates the translation levels of KatA and KatB and that it has no influence on *oxyR* expression, we examined the effects of *trmB* inactivation on *oxyR* mRNA and OxyR protein levels. Expectedly, the *oxyR* mRNA and OxyR protein levels did not change in the *trmB* mutant strain compared with those in the wild type strain with and without H~2~O~2~ exposure (Figure [7C](#F7){ref-type="fig"} and [D](#F7){ref-type="fig"}). Most likely, the expression levels of *katA* and *katB* were directly modulated by *trmB* at the translational level.

DISCUSSION {#SEC4}
==========

In this study, we reveal an important role of PaTrmB-catalyzed m^7^G46 tRNA modification in the oxidative stress response of *P. aeruginosa*; such a role is most likely facilitated through positive regulation of the translation efficiency of catalase genes via a biased codon usage mechanism. PaTrmB catalyzes the formation of m^7^G tRNA modification at position 46 in the tRNA variable loop (Figures [2](#F2){ref-type="fig"} and [4](#F4){ref-type="fig"}). Twenty-three tRNAs were identified as PaTrmB substrates, including eleven novel substrates, namely, tRNA^Ala/GGC^, tRNA^Arg/ACG^, tRNA^Arg/CCG^, tRNA^Arg/CCU^, tRNA^Asp/GUC^, tRNA^His/GUG^, tRNA^Ile/GAU^, tRNA^Pro/GGG^, tRNA^Thr/CGU^, tRNA^Thr/GGU^ and tRNA^Val/GAC^ ([@B12],[@B13],[@B15],[@B16],[@B21],[@B41],[@B42]). Analysis of all *P. aeruginosa* tRNA sequences revealed an RG[G]{.ul}UC ([G]{.ul} represents G46) motif at the variable loop site in PaTrmB substrates. The sequence of *P. aeruginosa* m^7^G modification motif is slightly different from that of the RAG[G]{.ul}U motif in m^7^G-modified tRNAs isolated from mouse ESCs ([@B21]). However, RG[G]{.ul}UC motif was not detected in G46-containing tRNAs that do not serve as substrates or are poor substrates for PaTrmB; these tRNAs include tRNA^Leu/CAG^, tRNA^Leu/GAG^ and tRNA^Sec(p)/UCA^. Furthermore, analysis of tRNA secondary structure revealed that these three tRNAs contain a long variable loop (11--19 ribonucleotide long) belonging to class II tRNA ([Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). Thus, PaTrmB may not simply recognize the G46 residue as its substrate. Both the sequence and the structure of the variable loop in the tRNA substrate may be essential for the methyl transfer reaction.

The impact of tRNA modifications on the efficiency of translation is mostly studied in anticodon loop ([@B5],[@B22],[@B23]). Here, we report that *trmB*-mediated m^7^G modification at position 46 in the tRNA variable loop is specifically necessary for the optimal translation of Phe- and Asp-enriched mRNAs (Figure [5](#F5){ref-type="fig"}). To our knowledge, only a few reports have shown the impact of tRNA modifications outside the anticodon region on the efficiency of protein synthesis. In *E. coli*, disruption of the gene responsible for the formation of Ψ55 further reduces the translation efficiency of Arg-CGA-enriched mRNA ([@B30]). Ribosome footprinting analysis in mouse ESCs has revealed an essential role of m^7^G modification in the efficient recognition of codons decoded by m^7^G-modified tRNAs during the elongation step ([@B21]). However, the manner by which m^7^G46 specifically affects the translation of the codons decoded by tRNA^Phe/GAA^ and tRNA^Asp/GUC^ remains unknown.

Here, we demonstrate the essential role of *trmB* in oxidative stress response of *P. aeruginosa* and reveal that *trmB*-mediated m^7^G modification directly regulates *katA* and *katB* at the translational level (Figures [6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}). KatA and KatB are the major H~2~O~2~-detoxifying enzymes in *P. aeruginosa* ([@B37],[@B38]). The expression of *katA* and *katB* in *P. aeruginosa* are positively regulated by OxyR, a H~2~O~2~-sensing transcriptional regulator ([@B39],[@B40]). In addition to the induction of *katA* and *katB* mRNA levels by H~2~O~2~ via OxyR regulation, our data suggest an additional regulation of *katA* and *katB* expression via the enhancement of translation efficiency. This finding is supported by the codon reporter assay results (Figure [5](#F5){ref-type="fig"}). The translation efficiency of Phe- and Asp-enriched mRNAs increased upon exposure to H~2~O~2~, consistent with the H~2~O~2~-induced increased in m^7^G modification (Figures [5](#F5){ref-type="fig"} and [6B](#F6){ref-type="fig"}, [C](#F6){ref-type="fig"}). Interestingly, a comparison of the codon usage of *katA, katB* and *oxyR* revealed that the Phe-UUC, Asp-GAC and Asp-GAU codons were enriched in *katA* and *katB* compared with the full genome ([Supplementary Figure S6](#sup1){ref-type="supplementary-material"}). However, these codons are not enriched in *oxyR*, consistent with the observation that *trmB* had no effect on *oxyR* expression at either the transcriptional or translational level (Figure [7](#F7){ref-type="fig"}). Moreover, examination of the distribution of Phe and Asp codons showed that the Phe and Asp codons were clustered in *katA* (161FKWDFF, 179DFSD and 417DDD) and *katB* (182DDDSRRFDFF and 297FDFDPLD) but were separately distributed in *oxyR*. These observations strongly supported that translational regulation by TrmB depends on the usage and distribution of the Phe and Asp codons in the target genes of TrmB.

The percentage of cell survival (Figure [6A](#F6){ref-type="fig"}) and total activity of catalase (Figure [7A](#F7){ref-type="fig"}) of the *trmB* mutant strain were fully complemented when compared with those of the wild type strain, whereas the level of total m^7^G modification in *trmB* complemented strain was partially recovered (Figure [2](#F2){ref-type="fig"}). It has been established that the overexpression of plasmid DNA can alter cellular metabolism ([@B43]). Therefore, we hypothesized that the lack of full complementation may arise from *trmB* overexpression, which is driven by the *lacZ* promoter in the medium to high copy number pBBR1MCS-4 plasmid. In addition, the level of certain modifications varies between individual tRNAs in *P. aeruginosa* ([@B44]). The m^7^G modification level in tRNA^Trp/CCA^ was higher than that in tRNA^Arg/UCG^, suggesting variation in the methyl acceptance activity of each tRNA type ([@B44]). Despite the lower total m^7^G level in the *trmB* complemented strain compared with that in the wild type (Figure [2B](#F2){ref-type="fig"}), the level of m^7^G in tRNAs that contributed to the translational control by TrmB, e.g. tRNA^Phe/GAA^ and tRNA^Asp/GUC^, in the *trmB* complemented strain may be high enough to fully restore catalase activity and survival under H~2~O~2~ exposure.

In addition to *trmB*, few other tRNA-modifying genes play important roles in cell responses to oxidative stress. Our previous work on *P. aeruginosa* has described two examples of such genes, namely, *trmJ* and *ttcA. trmJ* gene encodes 2′-*O*-methyl transferase, which catalyzes tRNA modifications at position 32, such as 2′-*O*-methylcytidine (Cm32), 2′-*O*-methyluridine (Um32), and 2′-*O*-methyladenosine (Am32) ([@B27]). *ttcA* gene encodes putative 2-thiocytidine synthetase, which catalyzes the formation of 2-thiocytidine (s^2^C) ([@B45]). Mutation of either *trmJ* or *ttcA* alters the expression of H~2~O~2~-defense genes and confers H~2~O~2~ sensitivity in *P. aeruginosa* ([@B27],[@B45]). Moreover, H~2~O~2~-induced reprogramming of tRNA modification has been found in yeast *trm4*. Increase in Trm4-mediated m^5^C34 modification after exposure to H~2~O~2~ selectively enhances the translation of *rpl22a* gene enriched with the Leu-UUG codon. The *rpl22a* gene, which encodes the ribosomal protein Rpl22a, is involved in H~2~O~2~ resistance, allowing yeast cells to grow following H~2~O~2~ treatment ([@B29]). In addition, defects in *E. coli trmM* ([@B46]), yeast *trm7* ([@B47]) and *Drosophila dnmt2* ([@B48]), which are responsible for the formation of tRNA 6-methyladenosine (m^6^A37), 2′-O-methylcytidine (Cm32 and Cm34), and 5-methylcytidine (m^5^C38), respectively, also result in H~2~O~2~ sensitivity.

We observed an ∼2.6-fold increase in the transcription level of *trmB* following H~2~O~2~ treatment, and this finding might explain the slight increase in m^7^G level and the increased translation efficiency of Phe- and Asp-enriched transcripts following the same treatment (Figures [5](#F5){ref-type="fig"} and [6B](#F6){ref-type="fig"}, [C](#F6){ref-type="fig"}). To date, regulation of the expression of *trmB* and most tRNA-modifying genes has not yet been studied. Our previous study on *ttcA* gene, which encodes a putative 2-thiocytidine tRNA synthetase, has demonstrated that *ttcA* transcription is directly modulated by OxyR, a H~2~O~2~-sensing transcriptional regulator, via the derepression mechanism in response to H~2~O~2~ exposure ([@B45]). However, no putative OxyR-binding site was detected in the upstream region of *trmB*. The regulation of *trmB* expression needs further investigation.

Overall, we present herein the regulatory function of TrmB in the translational control of biased codon usage transcript in response to oxidative stress. We propose a possible model to explain the TrmB-mediated translational control of oxidative stress response. The amounts of m^7^G-modified tRNAs, such as m^7^G modified-tRNA^Phe/GAA^ and m^7^G modified-tRNA^Asp/GUC^, are increased by H~2~O~2~ treatment due to *trmB* upregulation, which subsequently enhances the translation efficiency of the transcripts enriched with the relevant Phe and Asp codons. As a consequence, the levels of KatA and KatB, in which Phe and Asp codons are enriched and which are critical for H~2~O~2~ resistance, are increased, enabling *P. aeruginosa* cells to survive during oxidative stress (Figure [8](#F8){ref-type="fig"}). Taken together, our work describes a novel function of m^7^G tRNA modification in translational regulation of the oxidative stress response of *P. aeruginosa*, and it highlights the importance of tRNA modification outside the anticodon region in the translational control.

![Proposed model for the TrmB-mediated translational control of the oxidative stress response of *P. aeruginosa*. The increased level of m^7^G-modified tRNA produced by PaTrmB following H~2~O~2~ exposure subsequently enhances the translation of genes encoding the H~2~O~2~-degrading enzymes, namely, KatA and KatB, in which Phe and Asp codons are enriched, allowing cell survival during oxidative stress. AA, amino acid; F, phenylalanine; D, aspartic acid.](gkz702fig8){#F8}
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